IR (KBr), ν (cm−1): 3256 (NH), 3083 (CH aromatic), 2955, 1489, 741 (CH aliphatic), 1610 (C=N), 1503
(C–N), 679 (C–S). 1H NMR (Thiazovivin in vitro DMSO-d 6) δ (ppm): 3.87 (s, 2H, CH2), 4.12 (d, J = 5 Hz, 2H, CH2), 5.02–5.13 (dd, J = 5 Hz, J = 5 Hz, 2H, =CH2), ARRY-438162 manufacturer 5.79–5.88 (m, 1H, CH), 7.40–8.56 (m, 10H, 10ArH), 10.13 (brs, 1H, NH). 5-Aminocyclohexyl-2-[(4,5-diphenyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl-1,3,4-thiadiazole (6c) Yield: 75.6 %, mp: 172–174 °C (dec.). Analysis for C23H24N6S2 (448.61); calculated: C, 61.58; H, 5.39; N, 18.73; S, 14.30; found: C, 61.61; H, 5.37; N, 18.76; S, 14.27. IR (KBr), ν (cm−1): 3190 (NH), 3093 (CH aromatic), 2972, 1467, 749 (CH aliphatic), 1620 (C=N), 681 (C–S). 1H NMR (DMSO-d 6) δ (ppm): 1.1–1.65 (m, 10H, 5CH2 cyclohexane), 3.03 (m, 1H, CH cyclohexane), 4.22 (s, 2H, CH2), 7.33–8.06 (m, 10H, 10ArH), 10.16 (brs, 1H, NH). 5-Aminophenyl-2-[(4,5-diphenyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl-1,3,4-thiadiazole (6d) Yield: 50.9 %, mp: 192–198 °C (dec.). Analysis for C23H18N6S2
(442.60); calculated: C, 62.42; H, 4.10; N, 19.00; S, 14.49; found: C, 62.36; H, 4.09; N, 18.97; S, 14.53. IR (KBr), ν (cm−1): 3199 (NH), 3011 (CH aromatic), 2968 (CH aliphatic), 1610 (C=N), 1504 (C–N), 683 (C–S). 1H NMR (DMSO-d 6) δ (ppm): 4.02 (s, 2H, CH2), 6.98–7.54 (m, 15H, 15ArH), 4EGI-1 clinical trial 10.42 (brs, 1H, NH). [5-Amino-(4-bromophenyl)]-2-[(4,5-diphenyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl-1,3,4-thiadiazole (6e) Yield: 89.4 %, mp: 203–205 °C (dec.). Analysis for C23H17BrN6S2 (521.45); calculated: C, 52.98; H, 3.29; N, 16.12; S, 12.30; Br, 15.32; found: C, 52.73; H, 3.27; N, 16.15; S, 12.27. IR (KBr), ν (cm−1): 3167 (NH), 3110
(CH aromatic), 2954, 1441 (CH aliphatic), 1602 (C=N), 680 (C–S). 1H NMR (DMSO-d 6) δ (ppm): 4.22 (s, 2H, CH2), 6.89–7.65 (m, 14H, 14ArH), 10.23 (brs, 1H, NH). [5-Amino-(4-chlorophenyl)]-2-[(4,5-diphenyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl-1,3,4-thiadiazole (6f) Yield: 94.7 %, mp: 215–218 °C (dec.). Analysis for C23H17ClN6S2 (477.00); calculated: C, 57.91; H, 3.59; N, 17.62; S, 13.44; Celecoxib Cl, 7.43; found: C, 57.71; H, 3.60; N, 17.58; S, 13.39. IR (KBr), ν (cm−1): 3245 (NH), 3065 (CH aromatic), 2977 (CH aliphatic), 1611 (C=N), 1506 (C–N), 695 (C–S). 1H NMR (DMSO-d 6) δ (ppm): 3.89 (s, 2H, CH2), 7.39–7.64 (m, 14H, 14ArH), 10.36 (brs, 1H, NH). [5-Amino-(4-methoxyphenyl)]-2-[(4,5-diphenyl-4H-1,2,4-triazol-3-yl)sulfanyl]methyl-1,3,4-thiadiazole (6g) Yield: 53.6 %, mp: 152–154 °C (dec.).